New York CTN Node Renewal for Addiction Treatment Trials
Official title: NIDA Clinical Trials Network: New York Node - Renewal-GY24 (CTN-0162)
Funded at New York University School of Medicine · NIH-11577685 · Data updated 2026-11-12
A large, multi-site effort based in New York to advance addiction care by designing and leading clinical trials and testing new therapies and delivery strategies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | March 1, 2026 |
| Project end | February 29, 2032 |
| Funding year | 2026 |
| Award (this year) | $298,261 |
| NIH project number | 3UG1DA013035-25S1 |
| Project ID | NIH-11577685 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with substance use disorders who receive care through participating health systems or community organizations.
✕Less likely to help
Patients outside participating sites or those not eligible for the trials may not directly benefit.
What this research studies
This grant supports the New York University School of Medicine and partners in Columbia University and other centers to run multi-site clinical trials on substance use disorders. It emphasizes collaboration with health systems and community providers, use of implementing science, and analysis of existing data to address new research questions. The focus is on improving how addiction care is delivered, tested, and scaled across diverse settings in the U.S. The NYN has a track record of leading trials and ancillary studies and plans to expand capacity and dissemination of findings.
Why it matters
Potential benefit: If successful, patients with addiction could gain access to more effective treatments and delivery approaches.
How similar studies have gone: The NYN has led multiple multi-site trials and ancillary studies, showing feasibility and impact of coordinated, large-scale addiction research.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Mcneely, Jennifer — New York University School of Medicine
- Study coordinator: Mcneely, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.